Gritstone Oncology Inc (OQ:GRTS)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
BioMarin Pharmaceutical (OQ:BMRN)
Allakos (OQ:ALLK)
Latest 10 SEC filings (by transaction date) for GRTS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 14/19 Feb 13/19 Yelensky Roman Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 14/19 Feb 13/19 Rousseau Raphael Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 14/19 Feb 13/19 Hawryluk Matthew Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 55,000  
Mar 14/19 Feb 13/19 Allen Andrew R Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 180,000  
Mar 14/19 Feb 13/19 Jones Erin Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 14/19 Feb 13/19 Bellemin Jean-Marc Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 14/19 Feb 13/19 Jooss Karin Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 6/19 Jan 29/19 Jones Erin Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Mar 6/19 Jan 29/19 Jones Erin Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $0.345
Oct 2/18 Oct 2/18 Woiwode Thomas Indirect Ownership Series B Convertible Preferred Stock C - Conversion -929,020  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for GRTS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 14/19 Feb 13/19 Yelensky Roman Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 14/19 Feb 13/19 Rousseau Raphael Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 14/19 Feb 13/19 Hawryluk Matthew Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 55,000  
Mar 14/19 Feb 13/19 Allen Andrew R Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 180,000  
Mar 14/19 Feb 13/19 Jones Erin Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 14/19 Feb 13/19 Bellemin Jean-Marc Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 14/19 Feb 13/19 Jooss Karin Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,000  
Mar 6/19 Jan 29/19 Jones Erin Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Mar 6/19 Jan 29/19 Jones Erin Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $0.345
Oct 3/18 Oct 2/18 Redmile Group, LLC Indirect Ownership Series C Convertible Preferred Stock C - Conversion -153,360  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $GRTS

  • No tweets found

StockTwits